Insomnia
122 results
101 - 122
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder- Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications: Cochrane systematic review
- Antidepressants for people with epilepsy and depression
- Systemic and topical antibiotics for chronic rhinosinusitis
- Sound therapy (using amplification devices and/or sound generators) for tinnitus
- Placebo interventions for all clinical conditions: Cochrane systematic review
- Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
- Antidepressants for the treatment of depression in people with cancer
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
- Ginkgo biloba for tinnitus
- Adjuvant therapy with antidepressants for the management of inflammatory bowel disease: Cochrane systematic review
- Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea
- Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
- Antidepressants plus benzodiazepines for adults with major depression
- Pharmacotherapies for sleep disturbances in dementia
- Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
- Budesonide for maintenance of remission in Crohn's disease
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Oral budesonide for induction of remission in ulcerative colitis
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
- Neuromodulators for pain management in rheumatoid arthritis